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	 Four	simple	and	specific	spectrophotometric	methods	were	developed	and	validated	for	the
simultaneous	 determination	 of	 binary	 mixture	 of	 ibuprofen and	 famotidine,	 using	 unified
regression	 equation.	 The	 proposed	 spectrophotometric	 procedures	 including,	 derivative
ratio,	ratio	subtraction,	dual	wavelength	and	mean	centering	of	ratio	spectra	do	not	require
any	separation	steps.	Accuracy,	precision	and	linearity	ranges	of	the	proposed	methods	were
determined	and	the	specificity	was	assessed	by	analysing	synthetic	mixtures	of	both	drugs.
The	methods	were	applied	to	a	pharmaceutical	formulation	and	the	results	obtained	showed
that	there	is	no	significant	difference	between	the	proposed	methods	and	the	reported	one
regarding	both	accuracy	and	precision.	
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1.	Introduction	
	
Ibuprofen	 (IBU)	 (Figure	 1a)	 is	 a	 non‐steroidal	 anti‐
inflammatory,	analgesic	and	antipyretic	drug	[1].	It	inhibits	the	
cyclo‐oxygenase	enzyme	which	catalyses	the	transformation	of	
unsaturated	 fatty	 acids	 to	 prostaglandins.	 This	 inhibition	 of	
the	 prostaglandin	 synthesis	 is	 the	 cause	 for	 the	 analgesic,	
antipyretic,	and	anti‐inflammatory	action	of	the	drug.	It	is	well	
absorbed	 orally	 and	 more	 than	 99%	 protein	 bound,	 exten‐
sively	metabolized	in	the	liver	and	little	is	excreted	unchanged	
[2].		
Famotidine	 (FAM)	 (Figure	1b)	 is	 a	 competitive	histamine	
H2‐receptor	 antagonist.	 Its	 main	 pharmacodynamic	 effect	 is	
the	 inhibition	 of	 gastric	 secretion	 [3].	 It	 serves	 as	 an	
alternative	to	proton‐pump	inhibitors	[4].	
Several	methods	have	been	reported	for	the	simultaneous	
determination	of	 IBU	and	FAM.	These	methods	 include	HPLC	
[5‐12],	 HPTLC	 [7]	 spectrophotometric	 methods	 [13,14].	 The	
aim	 of	 this	 work	 is	 to	 develop	 and	 conduct	 different	
application	 of	 the	 spectrophotometric	methods	 for	 resolving	
the	binary	mixture	of	 IBU	and	FAM,	either	 in	pure	form	or	 in	
their	 pharmaceutical	 preparation	 without	 preliminary	 sepa‐
ration	steps	using	unified	regression	equation	[15].	 
	
	
(a)	
	
	(b)	
	
Figure	1.	Chemical	structure	of	(a)	ibuprofen	and	(b)	famotidine.
	
2.	Experimental	
	
2.1.	Instrumentations	
	
Spectrophotometric	 measurements	 were	 carried	 out	 on	
Shimadzu	 1650	 UV‐PC	 spectrophotometer,	 using	 1.00	 cm	
quartz	cells.	Scans	were	carried	out	in	the	range	from	200‐400	
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nm	 at	 0.1	 nm	 intervals.	 For	 mean	 centering	 of	 ratio	 spectra	
(MCR)	 computations,	 Matlab®	 7	 was	 used	 along	 with	 PLS‐
toolbox.	
	
2.2.	Chemicals	and	reagents	
	
Sodium	 hydroxide	 and	methanol	 were	 supplied	 from	 El‐
Nasr	 Chemicals	 Company	 (ADWIC,	 Egypt).	 Ibuprofen	 was	
kindly	supplied	by	Western	Pharmaceutical	 Industries,	China,	
its	 purity	was	 labelled	 to	 be	 99.6%	 based	 on	 the	 company's	
analysis	certificate.	Famotidine	was	kindly	supplied	by	Kahira	
Company,	 Cairo,	 Egypt.	 Its	 purity	 was	 labelled	 to	 be	 99.8%	
based	 on	 the	 company's	 analysis	 certificate.	 Duexis®	 was	
kindly	supplied	from	Horizon	Pharma	Industry	and	taken	from	
Rite	Aid	Pharmacy	 (BN.	 91206),	 531	North	Glendale	Avenue,	
Glendale,	CA,	USA.	Each	tablet	contains	800	mg	ibuprofen	and	
26.6	mg	famotidine.	
	
2.3.	Standard	solutions	
	
Stock	 solutions	 of	 IBU and	 FAM	 (1000	 μg	 /mL)	 were	
prepared	by	dissolving	100	mg	of	both	drugs	in	100	mL	of	0.1	
M	NaOH. Working	solution	of	 IBU	 is	 the	 same	stock	solution.	
Working	 solution	 of	 FAM	 (100	 μg/mL)	 was	 prepared	 from	
stock	solution	of	FAM	by	dilution	with	0.1	M	NaOH.	 
	
2.4.	Procedures	
	
2.4.1.	Spectral	characteristics	 	
	
The	 absorption	 spectrum	 of	 300	 μg/mL	 of	 IBU	 and	 18	
μg/mL	FAM,	both	separately	and	in	a	laboratory	mixture	in	0.1	
N	NaOH	were	scanned	over	the	range	200‐400	nm	against	0.1	
N	NaOH	as	a	blank.	
	
2.4.2.	Linearity	
	
Standard	solutions	containing	50‐600	μg/mL	of	IBU	and	2‐
22	μg/mL	FAM	were	prepared	separately	in	0.1	N	NaOH.	The	
absorption	spectra	of	the	resulting	solution	were	measured	in	
the	range	of	200‐400	nm	and	stored	in	the	computer.	
	
2.4.3.	Construction	of	calibration	curves	
	
2.4.3.1.	Derivative	ratio	method	(DRM)	
	
The	stored	spectra	of	IBU	solutions	(50‐600	μg/mL)	were	
divided	 by	 the	 absorption	 spectrum	 of	 standard	 solution	 of	
FAM	 (18	 μg/mL),	 and	 the	 first	 derivative	 of	 the	 resulting	
spectra	were	 obtained.	 The	 regression	 equation	 between	 the	
IBU	 concentration	 and	 the	 first	 derivative	 at	 267	 nm	 was	
computed.	
	
2.4.3.2.	Ratio	subtraction	method	(RSM)		
	
The	stored	spectra	of	laboratory	prepared	mixtures	of	IBU	
solutions	 (50‐600	 μg/mL),	 and	 FAM	 (2‐22	 μg/mL)	 were	
divided	 by	 the	 absorption	 spectrum	 of	 standard	 solution	 of	
FAM	 (18	 μg/mL),	 and	 the	 constant	 value	 at	 a	 plateau	 region	
286‐298	 nm	was	 subtracted	 from	 the	 resulted	 spectra,	 after	
that	 the	 resulting	 spectra	 were	 multiplied	 by	 the	 FAM	 (18	
μg/mL).	The	regression	equation	between	the	IBU	spectrum	at	
264	 nm	 and	 the	 corresponding	 IBU	 standard	 concentrations	
was	computed.	
	
2.4.3.3.	Dual	wavelength	method	(DWM)	
	
The	absorbance	of	 IBU	solutions	at	243.6	and	261.4	nm	were	
measured	 and	 recorded.	 The	 difference	 between	 these	 two	
points	 was	 computed.	 The	 regression	 equation	 relating	 the	
difference	 between	 absorbance	 of	 IBU	 at	 the	 specified	
wavelengths	 and	 corresponding	 IBU	 concentrations	 was	
computed.	
	
2.4.3.4.	Mean	centering	of	ratio	spectra	method	(MCM)	
	
The	stored	spectra	of	IBU	solutions	(50‐600	μg/mL)	were	
divided	 by	 the	 absorption	 spectrum	 of	 standard	 solution	 of	
FAM	(18	μg/mL).	The	ratio	spectra	obtained	were	exported	to	
Matlab	 for	 subsequent	 calculation,	 then	 the	 first	 order	
absorption	 spectra	 of	 IBU	 were	 divided	 by	 the	 first	 order	
absorption	spectrum	of	standard	solution	of	FAM	(18	μg/mL),	
the	obtained	ratio	spectrum	was	then	mean	centred	at	290	nm	
vs	the	corresponding	concentrations	of	IBU	and	the	regression	
equations	were	computed.		
 
2.5.	Analysis	of	laboratory	prepared	mixtures	
	
For	preparation	of	laboratory	prepared	mixtures,	aliquots	
equivalent	 to	 50‐600	 μg	 of	 IBU	 and	 2‐22	 μg	 of	 FAM	 were	
accurately	transferred	from	their	working	solutions	(IBU	1000	
μg/mL	and	FAM	100	μg/mL,	 respectively)	 into	a	 series	of	10	
mL	volumetric	flasks	and	the	volume	was	completed	with	0.1	
N	NaOH.	The	spectra	of	 the	prepared	mixtures	were	scanned	
from	200‐400	nm	and	stored	in	the	computer.	The	procedure	
detailed	 under	 linearity	 for	 each	 method	 was	 followed	 and	
then	 IBU	 and	 FAM	 concentration	 was	 calculated	 using	 the	
corresponding	regression	equation.	
	
2.6.	Application	to	pharmaceutical	formulation	
	
Duexis®;	each	tablet	claimed	to	contain	800	mg	of	IBU	and	
26.6	mg	 of	 FAM.	 Five	 tablets	were	weighted,	 grinded	well	 in	
mortar.	Then	a	weight	 from	 the	powdered	 tablets	 equivalent	
to	one	tablet	was	 taken	and	sonicated	 in	0.01	N	NaOH	for	30	
min.	Then,	the	suspension	was	filtered	and	transferred	to	100	
mL	 volumetric	 flask	 and	 completed	 with	 0.01	 N	 NaOH.	
Appropriate	dilution	was	made	to	get	a	mixture	of	160	μg/mL	
IBU	 and	5.32	μg/mL	FAM.	 Standard	 addition	 techniques	was	
performed.	 The	 procedure	 detailed	 under	 linearity	 for	 each	
method	 was	 followed	 and	 then	 IBU	 and	 FAM	 concentration	
was	 calculated	 using	 the	 corresponding	 regression	 equation.	
When	carrying	out	the	standard	addition	technique,	the	tablet	
powder	 and	 pure	 IBU	 and	 FAM	 were	 mixed	 well	 together	
before	proceeding	in	the	above	mentioned	procedures.	
	
3.	Results	and	discussion	
	
The	main	problem	of	spectrophotometric	multicomponent	
analysis	 is	 the	 simultaneous	 determination	 of	 two	 or	 more	
compounds	 in	 the	 same	 mixture	 without	 preliminary	
separation	 [16].	 The	 main	 task	 of	 this	 work	 is	 to	 establish	
precise,	 simple,	 sensitive	 and	 accurate	 spectrophotometric	
analytical	methods	for	simultaneous	determination	of	IBU	and	
FAM	 in	 their	 bulk	 powders	 and	 pharmaceutical	 dosage	 form	
with	 satisfactory	 precision	 and	 accuracy	 [17].	 As	 well,	 to	
construct	 a	 statistical	 comparison	 between	 the	 ability	 of	 the	
proposed	methods	to	determine	both	drugs	in	their	pure	form,	
laboratory	 prepared	 mixture	 and	 in	 their	 pharmaceutical	
formulations.	Upon	scanning	the	absorption	spectra	of	IBU	and	
FAM	 in	 methanol	 (Figure	 2),	 it	 was	 found	 that	 FAM	 can	 be	
determined	at	286.8	nm	without	interference	from	IBU,	while	
no	 wavelength	 was	 found	 suitable	 for	 IBU	 determination	
without	FAM	interference.	Therefore,	four	spectrophotometric	
methods	were	applied	for	simultaneous	determination	of	 IBU	
and	FAM.		
For	the	choice	of	suitable	divisor	for	derivative	ratio,	ratio	
subtraction	 and	 mean	 centering	 methods,	 several	 concent‐
rations	 of	 FAM	were	 tried	 until	we	 got	 the	 divisor	 of	 choice	
which	 is	 18	 μg/mL.	 For	 derivative	 ratio	method,	 IBU	 spectra	
were	divided	by	FAM	divisor	as	shown	 in	Figure	3,	 then	 first	
derivative	spectrum	was	obtained	as	shown	in	Figure	4.	
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Figure	2.	Zero	order	spectrum	of	ibuprofen	300	μg/mL	(___)	and	famotidine	
10	μg/mL	(….).	
	
	
	
	
Figure	3.	Ratio	spectra	of	IBU	(50‐600	μg/mL)	using	(18	μg/mL)	FAM	as	a	
divisor.	
	
	
	
	
Figure	 4.	 First	 derivative	 of	 ratio	 spectra	 IBU	 50‐600	 μg/mL	 using	 (18	
μg/mL)	FAM	as	a	divisor.	
	
For	 ratio	 subtraction	 method,	 laboratory	 prepared	
mixtures	 were	 prepared	 as	 mentioned	 above,	 dividing	
laboratory	 prepared	mixtures	 over	 FAM	 divisor	 as	 shown	 in	
Figure	 5,	 subtraction	 the	 constant	 value	 at	 a	 plateau	 region	
(286‐298	 nm)	 as	 shown	 in	 Figure	 6	 then	 multiplication	 the	
spectra	by	FAM	divisor	 to	 obtain	 spectra	 of	 IBU	 as	 shown	 in	
Figure	7.		
For	dual	wavelength	method,	FAM	spectrum	at	243.6	and	
261.4	nm	have	the	same	measure,	otherwise	IBU	spectrum	at	
the	same	points	have	difference	in	measurement,	a	regression	
equation	was	computed	as	shown	Figure	2.	
The	 mean	 centering	 method	 at	 290.0	 nm,	 IBU	 concent‐
rations	over	FAM	ratio	spectra	were	calculated	using	compu‐
ter	program	as	mentioned	in	Figure	8.	
The	 mixture	 of	 ibuprofen	 and	 famotidine	 in	 methanol	
gives	two	peaks	at	264.0	and	266.0	nm,	respectively,	instead	of	
286.0	nm	(λmax	of	FAM),	this	observed	hypsochromic	shift	was	
due	to	quarternerization	of	tertiary	amine	of	FAM	in	methanol	
solvent.	But	 in	0.1	N	NaOH	solvent	show	absorbance	at	264.0	
and	286.8	nm	for	IBU	and	FAM,	respectively,	and	did	not	show	
any	 solvent	 effect	 on	 the	 wavelength	 of	 the	 mixture,	 so	 we	
used	 0.1	 N	 NaOH	 instead	 of	 methanol	 solvent	 to	 avoid	 the	
hypsochromic	shift	problem.		
During	application	process	of	pharmaceutical	formulation,	
we	found	that	it	is	so	difficult	to	make	a	filtration	of	the	tablet	
contents,	 if	 we	 used	 a	 0.1	 N	 NaOH	 solvent,	 we	 found	 that	
switching	 the	 solvent	 to	 0.01	 N	 NaOH	 makes	 the	 filtration	
process	easier	and	accurate.	
For	all	the	proposed	methods,	the	statistical	parameters	of	
the	 regression	 equations	 and	 the	 concentration	 ranges	 are	
shown	 in	Table	1.	Table	1	 shows	 that	 the	proposed	methods	
were	 applied	 for	 the	 determination	 of	 pure	 drugs	 and	
satisfactory	 results	 were	 obtained.	 Standard	 addition	
technique	 was	 performed	 as	 mentioned	 in	 Table	 2.	 The	
proposed	method	was	 successfully	 applied	 to	 the	 analysis	 of	
IBU	 and	 FAM	 in	 their	 laboratory	 prepared	 mixtures	 and	 in	
tablet	dosage	form,		Table	3.	
	
	
	
Figure	5.	Obtained	spectra	of	IBU	after	division	of	five	laboratory	prepared	
mixtures	by	FAM	18	μg/mL	as	a	divisor.	
	
	
	
	
Figure	6.	Obtained	spectra	of	IBU	after	division	of	five	laboratory	prepared	
mixtures	 by	 FAM	 18	 μg/mL	 as	 a	 divisor	 and	 subtraction	 of	 the	 constant	
value.
	
3.1.	Method	validation	
	
Validation	 was	 done	 according	 to	 ICH	 recommendations	
[18,19].	
	
3.1.1.	Linearity	
	
The	 linearity	 of	 the	methods	was	 evaluated	 by	 analyzing	
five	 concentrations	 of	 IBU	 and	 six	 concentrations	 of	 FAM	
ranging	 from	 50‐600	 μg/mL	 and	 2‐22	 μg/mL,	 respectively.	
Each	 concentration	was	 repeated	 three	 times.	 The	 assay	was	
performed	 according	 to	 the	 experimental	 conditions	
previously	mentioned.	The	linear	equations	were	summarized	
in	Table	1.	
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Table	1.	Regression	parameters	and	results	of	determination	of	pure	samples	of	IBU	and	FAM	by	the	proposed	spectrophotometric	methods.	
Parameters	 Famotidine	
DRM	 RSM DWM MCM FAM	c	
Linearity	 50‐600	μg/mL	 50‐600	μg/mL 50‐600	μg/mL 50‐600	μg/mL	 2‐22	μg/mL
Slope	 0.0044	 0.0018 0.0008 0.0036 0.00455
Intercept	 0.0096	 0.0095 ‐0.0003 ‐0.3608 0.0117	
Correlation	coefficient	(r)	 0.9998	 0.9997 0.9997 0.9992 0.9997	
Mean±SD	 101.14±0.680	 100.49±1.280 101.15±0.997 99.72±2.230	 100.21±1.774
RSD	 0.640	 1.273 1.079 2.240 1.770	
Precision	(%RSD)	 	 	
	Repeatability	a	 ±0.520	 ±1.154 3±2.14 0±2.16 ±0.841	
	Intermediate	precision	b	 ±0.540	 ±1.162 ±2.153 ±2.190 ±0.860	
a	Intraday	precision	(the	%RSD	of	3	different	concentrations	for	IBU	and	FAM)	/	3	replicates	each,	within	the	same	day).	
b	Interday	precision	(the	%RSD	of	3	different	concentrations	for	IBU	and	FAM)	/	3	replicates	each,	repeated	on	3	successive	days).	
c	Zero	order	at	286.6	nm.	
	
	
Table	2.	Determination	of	IBU	and	FAM	in	pharmaceutical	formulation	by	the	proposed	methods	and	application	of	standard	addition	technique.	
Pharmaceutical	formulation		
Duexis®
	
Tablets	BN.	91206	
Ibuprofen	 Famotidine
DRM	 RSM DWM MCM (At	286.6	nm)
Found	%	a	±	SD	 99.72±1.14	 100.05±1.30 100.79±0.94 100.39±1.02	 100.74±0.99
Pure	added	(µg/mL)	 100	 100 100 100 2.5	
200	 200	 200	 200	 5	
300	 300 300 300 7	
Recovery	%	b	 99.25	 100.60	 99.64	 100.54	 99.60	
100.60	 99.76	 100.50	 101.6	 98.76	
101.74	 101.6 101.6 99.80 100.6	
Mean±SD	 100.53±1.24	 100.65±0.92 100.58±0.98 100.55±0.93	 101.65±1.16
a	Average	of	three	determinations.	
b	Average	of	three	determinations.	
	
	
Table	3.	Determination	of	IBU	and	FAM	in	laboratory	prepared	mixtures	by	suggested	spectrophotometric	methods.	
Pharmaceutical	 Ibuprofen	 Famotidine	
DRM	 RSM DWM MCM (At	286.6	nm)
300	µg/mL	IBU	:	6	µg/mL	FAM	 100.83	 100.29	 101.40	 100.40	 98.37	
300	µg/mL	IBU	:	10	µg/mL	FAM	 99.39	 101.69 100.52 101.63 101.42	
300	µg/mL	IBU	:	14	µg/mL	FAM	 101.81	 101.90 98.62 98.50 98.78	
200	µg/mL	IBU	:	10	µg/mL	FAM	 98.36	 99.62 99.74 101.50 101.42	
400	µg/mL	IBU	:	10	µg/mL	FAM	 100.75	 100.85 100.90 99.76 101.42	
Mean±SD	 100.82±1.26	 100.87±0.95	 100.23±1.08	 100.35±1.29	 100.28±1.56	
	
	
	
	
	
Figure	7.	Obtained	spectra	of	IBU	after	division	of	five	laboratory	prepared	
mixtures	by	FAM	18	μg/mL	as	a	divisor,	subtraction	of	 the	constant	value,	
then	multiplication	by	FAM	18	μg/mL.	
	
	
	
	
Figure	8.	Mean	centering	of	IBU	(50‐600	μg/mL)	at	290	nm	using	FAM	18	
μg/mL	as	divisor.	
3.1.2.	Accuracy	
	
The	 accuracy	 of	 the	 results	was	 checked	 by	 applying	 the	
proposed	 methods	 for	 determination	 of	 different	 blind	
samples	 of	 IBU	 and	 FAM.	 The	 concentrations	 were	 obtained	
from	the	corresponding	regression	equations.	From	which	the	
percentage	 recoveries	 suggested	 good	 accuracy	 of	 the	
proposed	methods,	Table	1.	
	
3.1.3.	Range	
	
The	 calibration	 range	 was	 established	 through	 conside‐
rations	 of	 the	 practical	 range	 necessary	 according	 to	
adherence	to	Beer’s	law	and	the	concentration	of	IBU	and	FAM	
present	 in	 the	 pharmaceutical	 preparations	 to	 give	 accurate	
precise	and	linear	results,	Table	1.	
	
3.1.4.	Selectivity	
	
Selectivity	of	the	methods	was	achieved	by	the	analysis	of	
different	laboratory	prepared	mixtures	of	IBU	and	FAM	within	
the	 linearity	 range.	 Satisfactory	 results	 were	 obtained	 and	
shown	in	Table	1.	
	
3.1.5.	Precision	
	
3.1.5.1.	Repeatability	and	reproducibility	
	
They	were	determined	using	three	concentrations	of	each	
of	 IBU	 (100,	 200,	 500	 μg/mL)	 and	 FAM	 (2,	 10,	 18	 μg/mL)	
which	were	analysed	three	times	intra‐daily	and	inter‐daily	on	
three	different	days	using	the	proposed	methods.	The	relative	
standard	deviations	were	calculated,	Table	1.	
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Table	4.	Statistical	analysis	of	the	proposed	methods	and	the	reported	method	of	ibuprofen	and	famotidine	in	their	pure	powdered	form.	
Parameter	 IBU	 FAM	
DRM	 RSM	 DWM	 MCM Reported	method	[22] Zero	order	 Reported	method	[22]
Mean	 101.14	 100.49	 101.15	 99.72	 100.20	 100.21	 100.74	
±SD	 ±0.680	 ±1.280	 ±0.997	 ±2.230	 ±1.130	 ±1.774	 ±1.053	
n	 5	 5	 5	 5 5 6 6	
Variance	 0.462	 1.638	 0.994	 4.970 1.270 3.140 1.108	
t‐test	 1.56	(2.306)	 0.42	(2.306)	 1.46	(2.306) 0.59	(2.306) 0.77	(2.228)	 	
F‐test	 2.74	(6.39)	 1.28	(6.39)	 1.27	(6.39) 3.91	(6.39) 2.83	(5.05)	 	
The	figures	in	parenthesis	are	the	corresponding	theoretical	values	at	p	=	0.05.	
	
	
3.1.5.2.	Stability	
	
IBU	 and	 FAM	working	 solutions	 in	methanol	 showed	 no	
spectrophotometric	 changes	up	 to	4	weeks	when	 stored	 at	4	
°C.	
	
3.2.	Application	of	the	proposed	methods	for	assay	of	
tablets	
	
The	proposed	UV	methods	were	 applied	 for	 the	determi‐
nation	 of	 IBU	 and	 FAM	 in	 their	 combined	 pharmaceutical	
formulation	 Duexis®	 tablets	 and	 the	 results	 are	 shown	 in	
Table	 2.	 The	 good	 percentage	 recoveries	 confirm	 the	 suita‐
bility	of	 the	proposed	methods	 for	 the	 routine	determination	
of	these	components	in	their	combined	formulation.	
Statistical	 analysis	 of	 the	 proposed	 methods	 and	 the	
reported	 method	 [20]	 was	 done	 as	 mentioned	 in	 Table	 4	
showing	no	significant	difference	between	them. 
	
4.	Conclusion	
	
In	 this	 work,	 four	 simple,	 sensitive	 and	 precise	 spectro‐
photometric	 methods	 were	 applied	 for	 the	 simultaneous	
analysis	 of	 binary	mixture	 of	 ibuprofen	 and	 famotidine	 with	
minimum	 manipulation	 steps.	 They	 do	 not	 need	 any	
sophisticated	 apparatus	 or	 a	 special	 program	 and	 could	 be	
easily	 applied	 in	 quality	 control	 laboratories,	 either	 in	 their	
pure	bulk	powders	and	in	dosage	form	[14].	
	
References	
	
[1]. O'Neil,	M.	J.	The	Merck	Index	‐	An	Encyclopedia	of	Chemicals,	Drugs,	
and	Biologicals.	13th	Edition,	Whitehouse	Station,	NJ:	Merck	and	Co.,	
Inc.,	2001.	
[2]. Katzung,	 B.	 G.;	 Furst,	 D.	 E.	 Basic	 and	 clinical	 pharmacology,	 7th	 ed.,	
Appliton	and	Lang	Stamford,	Connecticut,	1998.		
[3]. Elzanfaly,	E.	S.;	H.	E.	Zaazaa.;	Soudi,	A.	T.;	Salem,	M.	Y.	Acta	Chim.	Slov.	
2015,	62,	45‐51.		
[4]. Brophy,	G.	M.;	Bidwell,	K.	L.	Neurocrit.	Care	2010,	13,	176‐181.		
[5]. Kumar,	S.	A.;	Debnath,	M.;	Rao,	J.	V.	L.	N.	S.;	Sankar,	D.	G.	Int.	J.	Pharm.	
Sci.	Res.	2014,	5(9),	3829‐3839.		
[6]. Gracy,	S.;	Kumar,	S.	A.;	Debnath,	M.;	Rao,	 J.	V.	L.	N.	S.;	Sankar,	D.	G.;	
Mounika,	T.	A.	Int.	J.	Pharm.	Sci.	Res.	2014,	5(4),	300‐305.		
[7]. Sekhar,	 V.	 R.;	 Reddy,	 Y.	 P.;	 Ramalingam,	 P.;	 Theja,	 D.	 H.	Der.	 Phar.	
Sinica	2013,	4(2),	160‐170.		
[8]. Shah,	D.	A.;	Suthar,	D.	J.;	Baldania,	S.	L.;	Chhalotiya,	U.	K.;	Bhatt,	K.	K.	
ISRN	Anal.	Chem.	2012,	2012,	Article	ID	674392,	1‐5.		
[9]. Nyola,	N.;	Jeyabalan	G.	S.	J.	Appl.	Pharm.	Sci.	2012,	2(5),	79‐83.		
[10]. Ahirrao,	V.	K.;	Pawar,	R.	P.	Res.	J.	Pharm.	Sci.	2013,	2(4),	1‐9.		
[11]. Krishnaveni,	G.;	Sathyannarayana,	P.	V.	V.	Int.	J.	Pharma	Bio	Sci.	2013,	
4(3),	655‐662.		
[12]. Algobahi,	K.	M.;	Younis,	Y.	M.	H.	Int.	J.	Res.	Pharm.	Sci.	2012,	2(3),	69‐
80.		
[13]. Prasad,	 P.	 R.;	 Bhuveneswari,	 K.;	 Murarilal,	 M.;	 Rajani,	 K.	 Der	
Pharmacia	Let.	2015,	7(1),	232‐237.		
[14]. Wani,	Y.	B.;	Patil,	D.	D.	Int.	J.	Pharm.	Pharm.	Sci.	2013,	5(3),	358‐363.		
[15]. Lotfy,	H.	M.;	Hegazy,	M.	 A.	M.	 Spectrochim.	Acta	A	2013,	 113,	 107‐
114.		
[16]. Fayez,	Y.	M.	Spectrochim.	Acta	A	2014,	132,	446‐451.		
[17]. Lotfy,	 H.	 M.;	 Hegazy,	 M.	 A.	 M.;	 Abdel‐Gawad,	 S.	 A.	 N.	 Eur.	 J.	 Chem.	
2013,	4(4),	414‐421.		
[18]. Validation	of	Analytical	Procedures:	Text	and	Methodology	Q2	(R1),	
ICH,	1997.		
[19]. Abdel‐Aleem,	 E.	 A.;	 Hegazy,	 M.	 A.;	 Sayed,	 N.	 W.;	 Abdelkawy,	 M.;	
Abdelfatah,	R.	M.	Spectrochim.	Acta	A	2015,	136,	707‐713.		
[20]. Zaazaa,	H.	E.;	Elzanfaly,	E.	 S.;	 Soudi,	A.	T.;	 Salem,	M.	Y.	Spectrochim.	
Acta	A	2015,	143,	251‐255.		
	
	
